期刊文献+

非肌层浸润性上尿路尿路上皮癌5年随访生存分析及其预后相关因素研究 被引量:12

The prognostic factors and predictive model of non-muscle invasive upper tract urothelial carcinoma:a survival analysis based on follow up over 5 years
原文传递
导出
摘要 目的 分析非肌层浸润性上尿路尿路上皮癌(non-muscle invasive upper tract urothelial carcinoma,NMIUTUC)患者长期生存情况及其相关预后因素,并构建基于中国人群的列线图模型.方法 回顾性分析2000年1月至2013年12月收治的253例NMIUTUC患者的临床和随访资料,男100例,女153例.年龄25~ 90岁,平均67岁.肾盂癌127例,输尿管癌126例.多发肿瘤65例,单发肿瘤188例.肿瘤长径>5 cm者237例,≤5 cm者16例.乳头状肿瘤243例,非乳头状肿瘤10例.合并同侧肾积水147例.淋巴结转移6例.行腹腔镜手术162例,开放手术91例.行肾输尿管全长切除术244例,输尿管部分切除术9例.结果 本组253例随访4 ~ 151个月,中位时间55个月.40例(15.8%)死于肿瘤,84例(33.2%)出现膀胱复发.淋巴结转移(P =0.046),原发灶位于肾盂(P =0.044),合并同侧肾积水(P =0.039),合并慢性肾脏病(P =0.008)和男性(P =0.034)为NMIUTUC患者术后肿瘤特异性死亡的独立危险因素.而肿瘤多发(P =0.018),合并同侧肾积水(P =0.035)的患者更易出现术后膀胱复发.构建的用于预测NMIUTUC患者术后肿瘤特异性生存率的列线图模型的一致性指数为0.72.结论 NMIUTUC患者术后肿瘤特异性生存良好,膀胱复发率与肌层浸润性上尿路尿路上皮癌相当,且复发较晚.淋巴结转移、原发灶位于肾盂、合并同侧肾积水、合并慢性肾脏病和男性为术后肿瘤特异性死亡的独立危险因素.肿瘤多发、合并同侧肾积水的患者更易膀胱复发. Objective to evaluate the prognostic factors of non-muscle invasive upper tract urothelial carcinoma (NMIUTUC) and construct prognostic model for Chinese patients.Methods A retrospective study including 253 patients who were diagnosed with NMIUTUC in our hospital and received Radical nephroureterectomy (RNU) or partial ureterectomy during January of 2000 to December of 2013.Of all the 253 patients,100 were male and 153 were female,average age was 67 (range:25-90),244 received RNU and 9 received partial ureterectomy.Results The median follow-up time was 55 (range:4-151) months,and during follow-up,40 (15.8%) patients were died for cancer,84 (33.2%) patients developed intravesical recurrence.The independent prognostic factors of cancer-specific mortality were lymph nodes metastasis (P =0.046),main tumor locate in pelvis (P =0.044),ipsilateral hydronephrosis (P =0.039),higher chronic kidney disease (CKD) stage (P =0.008) and male gender (P =0.034),while patients with multifocality tumor or ipsilateral hydronephrosis more likely developed intravesical recurrence.Conclusion NMIUTUC has a better cancer-specific survival,the intravesical recurrence was equivalent to UTUC but later.Lymph nodes metastasis,main tumor locate in pelvis,ipsilateral hydronephrosis,CKD stage and male gender independently associated with cancer-specific mortality,while patients with multifocality tumor or ipsilateral hydronephrosis more likely developed intravesical recurrence.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2016年第3期190-194,共5页 Chinese Journal of Urology
基金 国家自然科学基金(81372746)
关键词 非肌层浸润性上尿路尿路上皮癌 生存分析 预后因素 列线图 Non-muscle invasive upper tract urothelial carcinoma Survival analysis Prognostic factor Nomogram
  • 相关文献

参考文献17

  • 1Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update[ J]. Eur Urol, 2013,63 : 1059-1071. DOI : 10. 1016/j. eururo. 2013.03. 032.
  • 2周利群,李学松,熊耕砚.中国人群上尿路尿路上皮癌新进展[J].北京大学学报(医学版),2014,46(4):504-506. 被引量:44
  • 3桂惠明,王志平.上尿路尿路上皮癌预后因素研究进展[J].中华泌尿外科杂志,2013,34(3):232-234. 被引量:9
  • 4Greene FL, Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC [J]. J Surg Oncol,2009,99:269-272. DOI : 10. 1002/jso. 21237.
  • 5Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial ( transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee [J]. Am J Surg Pathol, 1998,22:1435-1448.
  • 6Harrell FJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors [J]. Star Med, 1996,15:361-387.
  • 7Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis[J]. J Clin Oncol,2008,26:1364- 1370. DOI: 10. 1200/JCO. 2007.12. 9791.
  • 8Abouassaly R, Alibhai SM, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma[J]. Urology, 2010,76: 895-901. DOI: 10. 1016/j. urology. 2010.04. 020.
  • 9Fang D, Xiong GY, Li XS, et al. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience [J]. J Formos Med Assoc,2014,113:820-827. DOI: 10. 1016/j. jfma. 2013.11. 004.
  • 10李卫华,杨莉,苏涛,宋毅,李晓玫.服用含马兜铃酸成分药物对尿毒症透析患者伴发尿路移行细胞癌的影响[J].中华医学杂志,2005,85(35):2487-2491. 被引量:29

二级参考文献81

  • 1李卫华,杨莉,苏涛,宋毅,李晓玫.服用含马兜铃酸成分药物对尿毒症透析患者伴发尿路移行细胞癌的影响[J].中华医学杂志,2005,85(35):2487-2491. 被引量:29
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 3Chen CY,Liao YM,Tsai WM,et al.Upper urinary tract urothelial carcinoma in eastern Taiwan:high proportion among all urothelial carcinomas and correlation with chronic kidney disease.J Formos Med Assoc,2007,106:992-998.
  • 4National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Am J Kidney Dis,2002,39(Suppl):241-246.
  • 5Kang CH,Yu TJ,Hsieh HH,et al.The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.Cancer,2003,98:1620-1626.
  • 6Palou J,Rodríguez-Rubio F,Huguet J,et al.Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.J Urol,2005,174:859-861.
  • 7Hurle R,Losa A,Manzetti A,et al.Upper urinary tract tumors developing after treatment of superficial bladder cancer:7-year follow-up of 591 consecutive patients.Urology,1999,53:1144-1148.
  • 8Landis SH,Murray T,Bolden S,et al.Cancer statistics 1998.CA Cancer J Clin,1998,48:6-29.
  • 9Yang MH,Chen KK,Yen CC,et al.Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan.Urology,2002,59:681-687.
  • 10Chung SD,Huang KH,Lai MK,et al.CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.Am J Kidney Dis,2007,50:743-753.

共引文献84

同被引文献113

引证文献12

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部